These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 2668407

  • 1. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups.
    Pollare T, Lithell H, Mörlin C, Präntare H, Hvarfner A, Ljunghall S.
    J Hypertens; 1989 Jul; 7(7):551-9. PubMed ID: 2668407
    [Abstract] [Full Text] [Related]

  • 2. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.
    Pollare T, Lithell H, Selinus I, Berne C.
    BMJ; 1989 Apr 29; 298(6681):1152-7. PubMed ID: 2500169
    [Abstract] [Full Text] [Related]

  • 3. Effects of selective alfa 1 and beta 1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity.
    Andersson PE, Johansson J, Berne C, Lithell H.
    J Hum Hypertens; 1994 Mar 29; 8(3):219-26. PubMed ID: 8006923
    [Abstract] [Full Text] [Related]

  • 4. Metabolic effects of antihypertensive therapy with a calcium antagonist.
    Pool PE, Herron JM, Rosenblatt S, Reeves RL, Nappi JM, Staker LV, DiPette DJ, Evans RR.
    Am J Cardiol; 1988 Oct 05; 62(11):109G-113G. PubMed ID: 3051991
    [Abstract] [Full Text] [Related]

  • 5. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
    Giugliano D, Acampora R, Marfella R, De Rosa N, Ziccardi P, Ragone R, De Angelis L, D'Onofrio F.
    Ann Intern Med; 1997 Jun 15; 126(12):955-9. PubMed ID: 9182472
    [Abstract] [Full Text] [Related]

  • 6. Exercise capacity and hemodynamics in persons aged 20 to 50 years with systemic hypertension treated with diltiazem and atenolol.
    Luurila OJ, Gröhn P, Heikkilä J, Hämäläinen L, Härkönen R, Idänpään-Heikkilä U, Kohvakka A, Rytkönen U, Setälä M, Sundberg S.
    Am J Cardiol; 1987 Oct 01; 60(10):832-5. PubMed ID: 3310576
    [Abstract] [Full Text] [Related]

  • 7. Insulin sensitivity following treatment with the alpha 1-blocker bunazosin retard and the beta 1-blocker atenolol in hypertensive non-insulin-dependent diabetes mellitus patients.
    Eriksson JW, Jansson PA, Foley K, Lithell H.
    J Hypertens; 1996 Dec 01; 14(12):1469-75. PubMed ID: 8986932
    [Abstract] [Full Text] [Related]

  • 8. A comparison of the metabolic effects of captopril and atenolol on glucose, insulin and lipoproteins in patients with mild-to-moderate essential hypertension.
    Maritz FJ, Weich HF, Schoeman HS.
    S Afr Med J; 1995 Dec 01; 85(12 Pt 2):1342-5. PubMed ID: 8600607
    [Abstract] [Full Text] [Related]

  • 9. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.
    Myburgh DP, Gordon NF.
    Am J Cardiol; 1987 Nov 01; 60(13):1092-5. PubMed ID: 3314458
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension.
    Weir MR, Josselson J, Giard MJ, Warren JB, Posner JN, Lam YW, Zaske DE, Saunders E.
    Am J Cardiol; 1987 Dec 14; 60(17):36I-41I. PubMed ID: 3318375
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardiopulmonary response during exercise of a beta 1-selective beta-blocker (atenolol) and a calcium-channel blocker (diltiazem) in untrained subjects with hypertension.
    Cohen-Solal A, Baleynaud S, Laperche T, Sebag C, Gourgon R.
    J Cardiovasc Pharmacol; 1993 Jul 14; 22(1):33-8. PubMed ID: 7690093
    [Abstract] [Full Text] [Related]

  • 15. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Lakshman MR, Reda DJ, Materson BJ, Cushman WC, Freis ED.
    Arch Intern Med; 1999 Mar 22; 159(6):551-8. PubMed ID: 10090111
    [Abstract] [Full Text] [Related]

  • 16. Metabolic effects of a change in antihypertensive treatment.
    Lithell H, Aberg H, Selinus I.
    Am J Med; 1986 Feb 14; 80(2A):114-9. PubMed ID: 3511690
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.